社團指南

WHO Guidance on AI in Health

WHO guidance on AI in health emphasizes human rights, safety, transparency, accountability, inclusion, and ongoing evaluation.

  • 閱讀時間3分鐘
  • 最後更新
本頁閱讀時間3分鐘
  1. 概述
  2. 深入探討
  3. 戰略影響
  4. The Future of WHO Guidance on AI in Health
  5. 現實世界的實施
  6. 風險與防護欄
  7. 實施路線圖
  8. 不斷探索
  9. 常見問題

概述

These are governance principles, not a product certification or a substitute for local law. Health systems should involve affected people, assess risks through the lifecycle, and ensure that AI supports rather than displaces human decision-making.

深入探討

The World Health Organization’s guidance on ethics and governance of AI for health sets out principles for designing, developing, and using AI in ways that protect people and public interests. Its framework calls for human autonomy, safety and well-being, transparency, responsibility and accountability, inclusion and equity, and responsiveness and sustainability. These principles apply across the lifecycle, from deciding whether AI is appropriate to monitoring how it works in practice. WHO emphasizes that people should remain in control of healthcare systems and medical decisions, and that privacy and confidentiality should be protected. AI should be developed for well-defined use cases, with quality controls and meaningful information about design and limitations. Organizations should establish mechanisms for questioning decisions and redress when people are harmed. Inclusion requires attention to who benefits, who is left out, and how access is distributed. The guidance is normative and does not certify a product or replace national regulation. Health systems can use it to build governance: define accountability, engage patients and health workers, assess bias and safety, protect data, and monitor real-world use. WHO’s later guidance on large multimodal models applies similar principles to generative AI, urging careful evaluation and human oversight. Governance should be adapted to local law and health-system capacity. Consider procurement, workforce effects, and how patients can opt out or ask questions. Assign responsibility for responding when a system behaves unexpectedly.

戰略影響

風險與安全

災難性和日常的人工智慧危害都取決於誰了解風險以及誰能夠採取行動。

更明確的決策

民眾和專業素養決定強而有力的安全政策在政治上是否可行。

突破炒作

清晰的解釋可以減少炒作、實驗室公關和模糊道德劇場的影響。

The Future of WHO Guidance on AI in Health

WHO and national bodies continue to develop guidance as new AI capabilities enter health systems. More capable generative models increase the importance of measuring benefit before routine use and maintaining privacy, accountability, and human oversight. Health organizations can build trust through transparent limits, community participation, and continuous evaluation. Ethical governance is an ongoing responsibility shared by developers, providers, governments, and affected people. Evidence of benefit and harm should inform revisions. Include feedback from affected communities and evaluate outcomes after system changes.

現實世界的實施

A health ministry includes clinicians and patient groups in AI governance planning.

A hospital establishes a way to report and investigate algorithm-related harm.

A developer documents data limits and evaluates performance in intended settings.

A public agency checks whether AI access benefits groups equitably.

風險與防護欄

  • 將存在風險視為科幻小說,同時能力複合。

  • 混淆了表面產品安全與高度自治下的對準。

  • 只給非英語和非專業觀眾留下低品質的資源。

實施路線圖

  1. 單獨的產品危害、誤用和失控/失調風險。

  2. 詢問哪些證據會改變您對時間表和嚴重性的看法。

  3. 比起行銷主張,更喜歡主要來源和具體評估。

  4. 確定一條行動路徑:職業、政策、資金或技能——而不僅僅是意識。

不斷探索

Free newsletter

Get the daily AI briefing

Three verified AI stories every weekday morning, written in plain English. Free forever, no ads.

One email each weekday. Unsubscribe in one click. We never sell or share your address.

Test yourself

Take the WHO Guidance on AI in Health quiz

Instant feedback on every answer, and a shareable certificate with a verifiable ID once you pass a course.

開始測驗

Support free AI education. AI Understanding is a 501(c)(3) nonprofit — no ads, no paywall, ever. Make a donation

常見問題

What is WHO Guidance on AI in Health?

WHO guidance on AI in health emphasizes human rights, safety, transparency, accountability, inclusion, and ongoing evaluation. These are governance principles, not a product certification or a substitute for local law. Health systems should involve affected people, assess risks through the lifecycle, and ensure that AI supports rather than displaces human decision-making.

What does WHO’s AI-in-health guidance provide?

WHO guidance sets principles and recommendations, not product certification.

Is WHO guidance a product certification?

The guide distinguishes ethical principles from legal authorization.

Which disclosure most directly explains a health AI tool’s intended use, evidence, and limitations?

Transparency should help people understand the system and its use.

Who shares responsibility for ethical AI in health?

WHO frames governance as a shared stakeholder responsibility.